Daniel Clark

Stock Analyst at Leerink Partners

(0.45)
# 3,884
Out of 4,771 analysts
3
Total ratings
n/a
Success rate
-6.37%
Average return

Stocks Rated by Daniel Clark

Elanco Animal Health
Dec 2, 2024
Initiates: Market Perform
Price Target: $14
Current: $10.81
Upside: +29.51%
IDEXX Laboratories
Dec 2, 2024
Initiates: Outperform
Price Target: $500
Current: $419.52
Upside: +19.18%
Zoetis
Dec 2, 2024
Initiates: Outperform
Price Target: $215
Current: $164.43
Upside: +30.75%